HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Reckitt Benckiser Group PLC

www.rb.com

Latest From Reckitt Benckiser Group PLC

German Expert Panel Opposes OTC Ibuprofen/Phenylephrine Combo, Hydrocortisone 1%

Two prescription-to-OTC switch applications rejected by Germany’s Expert Committee for Prescription: preparations containing a combination of ibuprofen and phenylephrine hydrochloride and hydrocortisone 1% for external use.

Health OTC Drugs

Romania’s OTC Market in 2018: Colds And Flu Epidemic Help Boost Sales By 14%

Romanian self-care industry association, RASCI, provides HBW Insight with an exclusive viewpoint on the country's OTC market in 2018. 

 

Health OTC Drugs

Sanofi Overcomes Series Of Challenges To Return Syndol OTC Migraine Treatment To UK After 5-Year Absence

Sanofi has overcome production challenges to bring its OTC migraine and tension headache treatment Syndol back to the UK market after more than five years away.
United Kingdom Health

Ouch! Two UK Analgesic Ad Complaints: Reckitt Rapped, Perrigo Pardoned

Two UK advertising complaint verdicts delivered by the MHRA, Reckitt Benckiser's Nurofen Express (upheld) and Perrigo's Solpadeine Max (not upheld).

Health OTC Drugs
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register